
浏览全部资源
扫码关注微信
南阳市中心医院生殖医学科
纸质出版日期:2021,
扫 描 看 全 文
王琳, 陈建玲. 亮丙瑞林与孕三烯酮分别联合腹腔镜剥除术治疗中重度子宫内膜异位症合并不孕的疗效研究[J]. 保健医学研究与实践, 2021,18(3):112-115.
Wang Lin, Chen Jianling. Study on the efficacy for the treatment of moderate-to-severe endometriosis combined with infertility of laparoscopic debridement combined with leuprolide and progesterone respectively[J]. Health Medicine Research and Practice, 2021,18(3):112-115.
王琳, 陈建玲. 亮丙瑞林与孕三烯酮分别联合腹腔镜剥除术治疗中重度子宫内膜异位症合并不孕的疗效研究[J]. 保健医学研究与实践, 2021,18(3):112-115. DOI:
Wang Lin, Chen Jianling. Study on the efficacy for the treatment of moderate-to-severe endometriosis combined with infertility of laparoscopic debridement combined with leuprolide and progesterone respectively[J]. Health Medicine Research and Practice, 2021,18(3):112-115. DOI:
目的探讨亮丙瑞林与孕三烯酮分别联合腹腔镜剥除术治疗中重度子宫内膜异位症合并不孕的临床疗效。方法选取2015年1月-2019年2月南阳市某医院收治的118例中重度子宫内膜异位症合并不孕患者为研究对象。采用随机数字表法将患者分为亮丙瑞林联合组(59例)和孕三烯酮联合组(59例)。亮丙瑞林联合组患者接受亮丙瑞林联合腹腔镜剥除术治疗
孕三烯酮联合组患者接受孕三烯酮联合腹腔镜剥除术治疗。比较2组患者治疗前后的主观症状评分、实验室指标[血清卵泡刺激素(FSH)、黄体生成素(LH)、基质金属蛋白酶-9(MMP-9)、金属蛋白酶组织抑制因子-1(TIMP-1)];比较2组患者的治疗效果及治疗后6个月内的复发率、妊娠率。结果亮丙瑞林联合组患者的治疗总有效率为94.92%
高于孕三烯酮联合组患者的93.22%
但差异无统计学意义(P>0.05)。治疗前
2组患者主观症状评分
血清FSH、LH、MMP-9及TIMP-1水平比较
差异均无统计学意义(P>0.05);治疗后
2组患者主观症状评分
血清FSH、LH、MMP-9及TIMP-1水平均低于治疗前
且亮丙瑞林联合组低于孕三烯酮联合组
差异均有统计学意义(P<0.05)。治疗后6个月随访
亮丙瑞林联合组、孕三烯酮联合组患者均脱落1例
亮丙瑞林联合组患者复发率为5.17%
低于孕三烯酮联合组的20.69%
差异有统计学意义(P<0.05);亮丙瑞林联合组患者妊娠率为60.34%
高于孕三烯酮联合组的55.17%
但差异无统计学意义(P>0.05)。结论亮丙瑞林联合腹腔镜剥除术治疗中重度子宫内膜异位症合并不孕
效果确切
且能够有效改善患者的主观症状
保护卵巢功能
预防疾病复发。
Objective To investigate the clinical efficacy of leuprolide and progesterone respectively combined with laparoscopic debridement for the treatment of moderate-to-severe endometriosis combined with infertility.Methods One hundred and eighteen patients with moderate-to-severe endometriosis combined with infertility admitted to a hospital in Nanyang from January 2015 to February 2019 were selected for the study.The patients were divided into the leuprolide combination group(59 cases) and proge sterone combination group(59 cases) using a random number table.Patients in the leuprolide combination group were treated with leuprolide combined with laparoscopic debridement
and patients in the proge sterone combination group were treated with proge sterone combined with laparoscopic debridement.The subjective symptom scores and laboratory indexes [serum follicle stimulating hormone(FSH)
luteinizing hormone(LH)
matrix metalloproteinase-9(MMP-9)
tissue inhibitory factor of metalloproteinase-1(TIMP-1)] before and after treatment were compared between the 2 groups;the treatment effects and the recurrence and pregnancy rates within 6 months after treatment were compared between the 2 groups.Results The total treatment efficacy of patients in the leuprolide combination group was 94.92%
which was higher than that of patients in the proge sterone combination group(93.22%)
but the difference was not statistically significant(P>0.05).Before treatment
the differences in subjective symptom scores
serum FSH
LH
MMP-9 and TIMP-1 levels were not statistically significant(P>0.05);after treatment
the subjective symptom scores
serum FSH
LH
MMP-9 and TIMP-1 level-s were lower in both groups than before treatment
and those in the leuprolide combination group was significantly lower than the proge sterone combination group(P<0.05).At 6-month follow-up after treatment
one case of detachment occurred in both the leuprolide combination group and the proge sterone combination group
and the recurrence rate was 5.17% in the leuprolide combination group
which was lower than that in the proge sterone combination group(20.69%)
with a statistically significant difference(P<0.05);the pregnancy rate was 60.34% in the leuprolide combination groupwhich was higher than that in the progesterone combination group(55.17 %)
but the difference was not statistically significant(P> 0.05).Conclusion The combination of leuprolide and laparoscopic debridement for the treatment of moderate-to-severe endometriosis combined with infertility is effective and can effectively improve the subjective symptoms of patients
protect ovarian function and prevent the recurrence of the disease.
亮丙瑞林孕三烯酮腹腔镜剥除术子宫内膜异位症不孕
LeuprolideProgesteroneLaparoscopic debridementEndometriosisInfertility
0
浏览量
31
下载量
1
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621